Schedule 13G

-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, C7pI00hDK8NTYZJ/ZuYeUaf7chMGUcpPnRvWQiX3GUU8MN37BxXYY3EKrPkx4WUV CI9b5mTNOGRO38zVwdAS5A== 0001193125-07-004397.txt : 20070110 0001193125-07-004397.hdr.sgml : 20070110 20070110133014 ACCESSION NUMBER: 0001193125-07-004397 CONFORMED SUBMISSION TYPE: SC 13G PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070110 DATE AS OF CHANGE: 20070110 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: WELLS FARGO & CO/MN CENTRAL INDEX KEY: 0000072971 STANDARD INDUSTRIAL CLASSIFICATION: NATIONAL COMMERCIAL BANKS [6021] IRS NUMBER: 410449260 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G BUSINESS ADDRESS: STREET 1: 420 MONTGOMERY STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94163 BUSINESS PHONE: 6126671234 MAIL ADDRESS: STREET 1: WELLS FARGO & COMPANY STREET 2: 420 MONTGOMERY STREET CITY: SAN FRANCISCO STATE: CA ZIP: 94163 FORMER COMPANY: FORMER CONFORMED NAME: NORWEST CORP DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: NORTHWEST BANCORPORATION DATE OF NAME CHANGE: 19830516 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: CV THERAPEUTICS INC CENTRAL INDEX KEY: 0000921506 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 431570294 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G SEC ACT: 1934 Act SEC FILE NUMBER: 005-47551 FILM NUMBER: 07522685 BUSINESS ADDRESS: STREET 1: 3172 PORTER DR CITY: PALO ALTO STATE: CA ZIP: 94304 BUSINESS PHONE: 6503848500 MAIL ADDRESS: STREET 1: 3172 PORTER DRIVE CITY: PALO ALTO STATE: CA ZIP: 94304 SC 13G 1 dsc13g.htm SCHEDULE 13G Schedule 13G

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

CV Therapeutics, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

126667104

(CUSIP Number)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

x Rule 13d-1(b)

¨ Rule 13d-1(c)

¨ Rule 13d-1(d)

*	The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

EXPLANATORY NOTE

This Schedule 13G is filed by Wells Fargo & Company on its own behalf and on behalf of any subsidiaries listed on Attachment A. Aggregate beneficial ownership reported by Wells Fargo & Company under Item 9 on page 2 is on a consolidated basis and includes any beneficial ownership separately reported herein by a subsidiary.


		13G
CUSIP NO.126667104


1		NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)

		Wells Fargo & Company
		Tax Identification No. 41-0449260
2		CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
		(a) ¨
		(b) ¨
3		SEC USE ONLY

4		CITIZENSHIP OR PLACE OF ORGANIZATION

		Delaware


NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		5 SOLE VOTING POWER

		5,811,027
		6 SHARED VOTING POWER

		0
		7 SOLE DISPOSITIVE POWER

		5,848,077
		8 SHARED DISPOSITIVE POWER

		0


9		AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

		5,864,817
10		CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

		Not applicable
11		PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

		10.30%
12		TYPE OF REPORTING PERSON

		HC


		13G
CUSIP NO.126667104


1		NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)

		Wells Capital Management Incorporated
		Federal ID No. 95-3692822
2		CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
		(a) ¨
		(b) ¨
3		SEC USE ONLY

4		CITIZENSHIP OR PLACE OF ORGANIZATION

		California


NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		5 SOLE VOTING POWER

		1,026,061
		6 SHARED VOTING POWER

		0
		7 SOLE DISPOSITIVE POWER

		5,731,376
		8 SHARED DISPOSITIVE POWER

		0


9		AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

		5,731,376
10		CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

		Not applicable
11		PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

		10.06%
12		TYPE OF REPORTING PERSON

		IA


		13G
CUSIP NO.126667104


1		NAME OF REPORTING PERSON I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY)

		Wells Fargo Funds Management, LLC
		Federal ID No. 94-3382001
2		CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
		(a) ¨
		(b) ¨
3		SEC USE ONLY

4		CITIZENSHIP OR PLACE OF ORGANIZATION

		Delaware


NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH		5 SOLE VOTING POWER

		4,784,966
		6 SHARED VOTING POWER

		0
		7 SOLE DISPOSITIVE POWER

		116,701
		8 SHARED DISPOSITIVE POWER

		0


9		AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

		4,784,966
10		CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

		Not applicable
11		PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9

		8.40%
12		TYPE OF REPORTING PERSON

		IA

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934

DISCLAIMER: Information in this Schedule 13G is provided solely for the purpose of complying with Sections 13(d) and 13(g) of the Act and regulations promulgated thereunder, and is not to be construed as an admission that Wells Fargo & Company or any of its subsidiaries is the beneficial owner of the securities covered by this Schedule 13G for any purpose whatsoever.

Item 1

(a)

Name of Issuer:

CV Therapeutics, Inc.

Item 1

(b)

Address of Issuer’s Principal Executive Offices:

3172 Porter Drive

Palo Alto, CA 94304

Item 2

(a)

Name of Person Filing:

Wells Fargo & Company

Wells Capital Management Incorporated

Wells Fargo Funds Management, LLC

Item 2

(b)

Address of Principal Business Office or, if None, Residence:

1. Wells Fargo & Company

420 Montgomery Street

San Francisco, CA 94104

2. Wells Capital Management Incorporated

525 Market Street

San Francisco, CA 94105

3. Wells Fargo Funds Management, LLC

525 Market Street

San Francisco, CA 94105

Item 2

(c)

Citizenship:

1. Wells Fargo & Company: Delaware

2. Wells Capital Management Incorporated: California

3. Wells Fargo Funds Management, LLC: Delaware

Item 2

(d)

Title of Class of Securities:

Common Stock

Item 2

(e)

CUSIP Number:

126667104

Item 3

The person filing is a:

1. Wells Fargo & Company: Parent Holding Company in accordance with 240.13d-1(b)(1)(ii)(G)

2. Wells Capital Management Incorporated: Registered Investment Advisor in accordance with Regulation 13d-1(b)(1)(ii)(E)

3. Wells Fargo Funds Management, LLC: Registered Investment Advisor in connection with Regulation 13d- 1(b)(1)(ii)(E)

Item 4

Ownership:

See items 5-11 of each cover page. Information as of December 31, 2006.

Item 5

Ownership of Five Percent or Less of a Class:

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following. ¨

Item 6

Ownership of More than Five Percent on Behalf of Another Person:

Not applicable.

Item 7

Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company:

See Attachment A

Item 8

Identification and Classification of Members of the Group:

Not applicable

Item 9

Notice of Dissolution of Group:

Not applicable

Item 10

Certification:

By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

Signature.

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete, and correct.

Date: January 8, 2007

WELLS FARGO & COMPANY

By:

/s/ Mark B. Kraske

Mark B. Kraske,

VP Trust Operations Management Support Services

ATTACHMENT A

The Schedule 13G to which this attachment is appended is filed by Wells Fargo & Company on behalf of the following subsidiaries:

Wells Capital Management Incorporated (1)

Wells Fargo Funds Management, LLC (1)

(1)	Classified as a registered investment advisor in accordance with Regulation 13d-1(b)(1)(ii)(E).

AGREEMENT

The undersigned hereby agree that the statement on Schedule 13G to which this Agreement is attached shall be filed by Wells Fargo & Company on its own behalf and on behalf of Wells Capital Management Incorporated.

Date: January 8, 2007

WELLS FARGO & COMPANY

By:

/s/ Mark B. Kraske

Mark B. Kraske, VP Trust Operations

Management Support Services

WELLS CAPITAL MANAGEMENT INCORPORATED


By:		/s/ Mai Shiver
		Mai Shiver, Chief Compliance Officer

AGREEMENT

The undersigned hereby agree that the statement on Schedule 13G to which this Agreement is attached shall be filed by Wells Fargo & Company on its own behalf and on behalf of Wells Fargo Funds Management, LLC.

Date: January 8, 2007

WELLS FARGO & COMPANY


By:		/s/ Mark B. Kraske
		Mark B. Kraske, VP Trust Operations Management Support Services

WELLS FARGO FUNDS MANAGEMENT, LLC

By:		/s/ Dorothy A. Peters
		Dorothy A. Peters, Chief Compliance Officer

-----END PRIVACY-ENHANCED MESSAGE-----